Indeed, it has been found that inhibition of PI3K can potentiate the effects of BRAF and MEK inhibitors in attenuating the growth of melanoma cells [21] and melanoma tumours in both animal xenograft models [15, 21] and genetically-engineered mouse tumour models mentioned above [15, 16]. This evidence concerns the gene PIK3CD and melanoma.